Testing a device to mark breast cancer for surgery and monitoring
Part of Cancer, Skin clinical trials.
This trial tests a device called OneMark that helps doctors find and track breast cancer during surgery and follow-up. It may help make sure the cancer is removed completely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in good general health and can have surgery with general anesthesia.
- If you can become pregnant, you must have gone through menopause (no period for 12 months or be over 60).
- You have a small breast tumor (less than 5 cm) that can be seen on an ultrasound.
- Your mammogram shows a suspicious finding (BI-RADS 4 or 5) or you have stage T1/T2 breast cancer visible on ultrasound.
- You are not pregnant or breastfeeding, and have not had chemotherapy in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
This trial looks at different methods doctors can use to locate a breast lesion using imaging, so it can be removed accurately during breast-conserving surgery. It may help your care team choose the best localization approach for your type and location of lesion.
This trial tests a new way to mark the area where breast cancer is removed during lumpectomy with oncoplastic reconstruction. The goal is to make follow-up radiation more precise and reduce the need for additional surgeries.
This study tests a new, non-invasive scanning tool that uses harmless electrical signals to look at breast tissue. It may help doctors evaluate breast conditions without surgery, which could be useful for diagnosis or monitoring treatment.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This study tests a new type of mammogram that might give clearer pictures of breast tissue. It is for women who are either scheduled for breast surgery or getting a regular mammogram.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.